My Medication Side Effects Are Too Popular

If she agrees, then Xinmei Cosmetics can indeed develop faster, but her equity will be diluted again.

And it's not just hers, the equity of Li's Group will also be diluted. I don't know if the group headquarters can agree to this.

It seems that I can only find my father.

An hour later, Li Xiner appeared in her father's office

"Dad, you must help me this time, I will never marry Gu Yinqi!

Li Zhixiong sighed: "Xin'er, it's not that Dad doesn't want to help you, but this time the group company can't continue to invest in you.

, but it will take two years to start making profits, and it will take three years to pay back, which is too long.

"Your mouth is a billion,

"But you don't like Gu Yinqi, Dad won't let you marry him, it's just that your Xinmei Cosmetics Company may not be able to keep it.

Family and harmony are the best.

Li Zhixiong didn't want to fight with his younger brother's family,

, the old man's shares will be given to whomever he wishes,

"Dad, I don't need one billion, just one hundred million. I don't want the company to give this money,

: But you give it to me.

"I talked to Mr. Fu of Xinming Pharmaceutical, and he decided to take out a new drug in Phase III clinical trials to lighten the skin color to buy shares in Xinmei Cosmetics.

"This is a drug that can whiten and lighten skin pigmentation. After it is introduced to the market, even if it is only in the Asian market, it will be very popular.

People will also like the effect of blemishes.

"As long as there is [-] million, my shares will not be diluted too hard, and with the support of Fu Liang, I will no longer have to be checked and balanced by the Li Group.

At that time, the equity held by her and the Fu family together will exceed [-]% of Xinmei Cosmetics.

, the Li Group also wants to control the company at will

Destiny?

And once she has fulfilled her promise to grandpa, will grandpa still support outsiders?

This company will still be managed by her Li Xiner in the future, so there will be no surprises.

After listening to his daughter's detailed explanation and asking some key questions, Li Zhixiong finally nodded.

One hundred million, he can still raise it.

Li Xiner's cooperation method is really good,

, Dad supports you this time, I hope you can be happy.Dad also believes that girls can run a company as well.

"Okay, Xin'er,

Two days later, Xinmei Cosmetics Co., Ltd. announced that it would accept Fu Liang's prescription to lighten skin color as a stake in the company, becoming the company's second-largest shareholder.

Hearing this news, Gu Xuanqi was going to explode with rage!

He bought a prescription for lightening pigmentation at a high price,

, isn't it useless?

Li Xiner made it clear that she wanted to fight against him!

And that Fu Liang, who has always been against him.

Not only Xinmei Cosmetics Co., Ltd., but also Tianlong Pharmaceutical's investment made him lose money.

"Fu Liang, this matter is over!"

Fu Gao didn't have time to pay attention to Gu Yinqi. He wanted to talk to Qiangniu about new drugs and immediately went overseas to talk about clinical practice!

PS: Ask for flowers, ask for evaluation, ask for collection! ! !

Chapter 4: Sleepy meets pillow, system L[-]

Dehua turned off the video call, his face a little tired but also a little excited.

The CEO of the company has returned to the United States, but he has left him in the East, giving him full control over the joint venture

And the president just gave him an order. If he can convince the Fu family to let Sutong stop synchronously conduct clinical trials in Europe and the United States, he can be promoted to the company's deputy.

General, responsible for the management of all drug research and development laboratories of the company.

This step is very important for Edward, and it is related to whether he can enter the core management of the company.

If this step is achieved, he may even have the opportunity to sit on the company's board of directors in the future.

If he can get the Fu family to license other drugs to J&J, or allow J&J to take a stake, he could be on the board this year.

It's just that he doesn't always have confidence in negotiating with the Fu family.

He entered the board of directors without asking for a step, but when he became the company's vice president, he did not want to miss this step.

At his age, the research and development ability has actually declined, and it is all supported by experience. He does not want to live in the laboratory all his life.

"The company really gave me a difficult task, I hope I can succeed.

Edward laughed at himself and called Fu Xinming.

But Fu Xinming told him that he had to talk to Fu Liang about the clinical affairs of medicines.

Edward thought about it and decided to go to the new drug research and development laboratory center of Xinming Pharmaceutical to find Fu Liang in person to show his sincerity.

"Dehua Bo Shi, do you want to plan the three-phase clinical trial to be launched all over the world?

Fu Liang was a little surprised, this was really a sleepy encounter with a pillow.

He quickly figured it out, which also echoed the interests of Johnson & Johnson.

The sooner a new drug is launched, the lower the probability of similar competitive drugs appearing in the market, and the greater the possibility of profit.

And if the project can be listed globally simultaneously, then the production and sales costs will be reduced, and the profit margin will be higher.

Edward saw Fu Liang's surprised expression, and explained a little embarrassedly: "Mr. Fu, because Quick Stop has not been listed on the market, or even received

Production and sales approval in your country.

"So it is impossible to directly carry out clinical phase III in Europe and the United States, it is possible to start from clinical phase II, or even start from clinical phase I in some regions.

"There is a simplified process for drug approvals in many regions, and we, Johnson & Johnson, have the confidence to make Sudden listed in the global market simultaneously.

"I know this request is a bit abrupt. When we talked about cooperation before, we didn't talk about this detail, but we talked about keeping shareholders' best interests.

Great interests, which also echo the interests of you and other shareholders of Xinming Pharmaceutical.

Originally, Fu Liang wanted Johnson & Johnson to help, but now,

, it seems that Johnson & Johnson came to ask him, then he can put forward conditions

"Dr. Edward, what you said is not impossible, but the joint venture requires us to inject another proportion of funds, and it needs to increase some

management costs.

Fu Liang crossed Erlang's legs and leaned on the back of the chair with a reluctant attitude.

"Mr. Xiaofu, you and Xinming Pharmaceutical are both short of cash now, don't you? Our first payment has already arrived, you only need to take out part of it.

Just inject it into the new joint venture, and we, Johnson & Johnson, will also inject it proportionally.

Edward is a little puzzled. You shouldn't be short of money, right?

Although the $[-] billion has to arrive in two instalments, the first time is also $[-] billion, and the money injected into the joint venture doesn't need to be that much at all.

, a few hundred million dollars is enough.

Fu Liang shook his head: "How come there is no shortage of money? The laboratory expenses are a lot of money, and I have to continue to develop new drugs, which will cost a lot of money. And

Our hair growth drug approval is about to come down, and we are also preparing to go abroad to conduct Phase III clinical trials, which will cost money.

Edward frowned and thought for a moment: "Mr. Xiao Fu, if Johnson & Johnson can help you with the Phase III clinical trials of hair growth drugs in Europe and the United States?

"As far as we can help you get the approval for production and listing, we only need the cost price, and we won't make a penny.

But I hope that if your new drug wants to find a partner in the overseas market, you will give priority to Johnson & Johnson.

Fu Liang looked at Edward and smiled slightly: "It's not just a hair growth medicine, but also a hair removal cream, a medicine to lighten the skin color, I hope the former life company

can help.

Edward hesitated for a moment, not just a drug, the cost of Johnson & Johnson would be too much,

However, he weighed it carefully. In this way, the relationship between Xinming Pharmaceutical and Johnson & Johnson will be more closely monitored. If Xinming Pharmaceutical has new

The special drugs, they Johnson & Johnson should be the first choice for cooperation.

I heard that the Orientals also like long-term and stable cooperation, and the Orientals are very particular about reciprocation. This time, they helped Xinming Pharmaceutical and Fu Liang.

In the future, Johnson & Johnson will not suffer.

"Okay, we, Johnson & Johnson, can agree. I'll report to the headquarters and try to start clinical trials next week.

Johnson & Johnson is very satisfied with Edward's ability to talk to Fu Liang about the clinical situation overseas, as for helping other drugs in the clinic.

They are also willing to accept it, it's a piggyback thing anyway.

And Fu Liang was even more satisfied with this. Johnson & Johnson took the initiative to help without any extra effort.

Johnson & Johnson's efficiency is very high, but in more than a week, the clinical documents of these drugs were obtained, and clinical trials could be started.

In clinical practice, the pharmaceutical experts of Johnson & Johnson are also staring at the clinical data, to be sure that everything is safe, especially the quick stop.

They were surprised to find that Pain Stop performed better than they expected.

Although it has only just started, all the patients who have taken it are full of praise.

What shocked the people of Johnson & Johnson even more was that the effects of medicines such as hair growth medicine and hair removal cream were far beyond their imagination.